[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Pages 427-428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00197]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public, limited only by room
seating. The meeting room accommodates 216 for public seating. Rooms
245, 246, and 247, adjacent to the meeting room, will be available once
the meeting room reaches capacity, providing up to 120 additional
seats. Time will be available for public comment. The meeting will be
webcast live via the World Wide Web; for instructions and more
information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.
DATES: The meeting will be held on February 27, 2019, 8:00 a.m. to 5:30
p.m., EST, and February 28, 2019, 8:30 a.m. to 3:30 p.m. EST.
ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications
Center, Building 19, Kent `Oz' Nelson Auditorium, Atlanta, Georgia
30329-4027.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD, telephone 404-639-8836, email
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Public Comment
Oral Public Comment: This meeting will include one 75-minute
session for oral public comment during which members of the public may
make an in-person public comment. The oral public comment session will
occur near the end of the first day's session on February 27, 2019 and
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
On-site, in-person registration for oral public comment at the meeting
will only be available if there is time remaining in the oral public
comment session after all individuals who submitted a request to make
an oral comment before the meeting have had an opportunity to speak.
There is no guarantee there will be an opportunity for on-site, in-
person registration for oral public comment, and all individuals
interested in requesting to make an oral public comment are strongly
encouraged to submit a request according to the instructions below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the February ACIP meeting must submit a
request at http://www.cdc.gov/vaccines/acip/meetings/ no later than
11:59 p.m., EDT, February 13, 2019. Interested persons must include
their name; the name of the group or organization the individual is
representing, if applicable; and contact information, including email
address, mailing address, and telephone number.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled 75-minute oral public
comment session, CDC will conduct a lottery to determine the speakers
for the scheduled session. CDC staff will notify individuals regarding
their request to speak by email by February 15, 2019. To accommodate
the significant interest in participation in the oral public comment
session of ACIP meetings, each speaker will be limited to 3 minutes,
and each speaker may only speak once per meeting. Interested persons
who are unable to make an oral public comment during this meeting are
invited to submit a written comment according to the instructions
below.
Written Public Comment: Written comments will be accepted up to 48
hours following the end of the ACIP Meeting. You may submit comments,
[[Page 428]]
identified by Docket No. CDC-201x-xxxx using the Federal eRulemaking
Portal: http://www.regulations.gov. Follow the instructions for
submitting comments. All submissions received must include the agency
name and Docket Number. All relevant comments received in conformance
with the regulations.gov suitability policy will be posted without
change to http://regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to http://www.regulations.gov. Written public
comments submitted by 72 hours prior to the ACIP meeting will be
provided to the ACIP members before the meeting.
Matters to be Considered: The agenda will include discussions on
human papillomavirus vaccines, pneumococcal vaccines, Japanese
encephalitis vaccines, influenza vaccines, anthrax vaccine, hepatitis
vaccines, Pertussis vaccine, herpes zoster vaccine, and meningococcal
vaccines. A recommendation vote is scheduled for anthrax vaccine,
Japanese encephalitis vaccines, and human papillomavirus vaccines.
Agenda items are subject to change as priorities dictate. For more
information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00197 Filed 1-25-19; 8:45 am]
BILLING CODE 4163-18-P